-->

Tag: Belzutifan

Home / Belzutifan

Categories

Belzutifan is approved by the USFDA for pheochromocytoma or paraganglioma

On May 14, 2025, the Food and Drug Administration sanctioned belzutifan (Welireg, Merck & Co., Inc.) for adult and pediatric patients aged 12 and older diagnosed with locally advanced, unresectabl...
belzutifan

Belzutifan has been approved by the FDA for malignancies linked to von Hippel-Lindau disease

August 2021: Belzutifan (Welireg, Merck), a hypoxia-inducible factor inhibitor, has been approved by the Food and Drug Administration for adult patients with von Hippel-Lindau disease who require ther...
belzutifan

Scan the code